SARATON KASALLIGINI ERTA TASHXISLASHDA mikroRNKLARDAN FOYDALANISH
Keywords:
saraton, mikroRNK, onkogen, diagnostika va prognoz, davolash.Abstract
Butun dunyo boʻylab katta intellektual va moliyaviy sa’y-harakatlarga qaramay, hozirgi vaqtda saratonni noinvaziv boʻlgan erta aniqlash uchun mos keladigan qonga asoslangan biomarkerlar mavjud emas. Kasallikning tarqalishini nazorat qilish va omon qolish imkoniyatlarini oshirish uchun erta tashxis qoʻyish juda muhimdir.
References
Paranjape T, Slack FJ, Weidhaas JB. MicroRNAs: tools for cancer diagnostics. 2009 nov; 58(11): 1546-1554. [PubMed] [Google Scholar]
Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75:843–54. [PubMed] [Google Scholar]
Saxena S, Jonsson ZO, Dutta A. Small RNAs with imperfect match to endogenous mRNA repress translation. Implications for off-target activity of small inhibitory RNA in mammalian cells. J Biol Chem. 2003;278:44312–9. [PubMed] [Google Scholar]
Bentwich I, Avniel A, Karov Y, et al. Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet. 2005;37:766–70. [PubMed] [Google Scholar]
Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D, Slack FJ. RAS is requlated by the let-7 microRNA family. Cell. 2005 Mar 11; 120(5): 635-47. [PubMed]
Let-7 expression defines two differentiation stages of cancer.
Shell S, Park SM, Radjabi AR, Schickel R, Kistner EO, Jewell DA, Feig C, Lengyel E, Peter ME. Let-7 expression defines two differentiation stages of cancer. Proc Natl Acad Sci U S A. 2007 Jul 3;104(27):11400-5. [Epub]
Yan LX, Huang XF, Shao Q, Huang MY, Deng L, Wu QL, Zeng YX, Shao JY. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. 2008 Nov;14(11):2348-60. [Epub]
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.